May 12, 2014 10:41 AM

$255 million offered for Lee’s Summit company Viracor-IBT Laboratories

The offer is from Eurofins Scientific, a publicly traded European company. Together with a satellite facility in California, the immunology, infectious disease and allergy testing company is primarily owned by Ampersand Capital, a private equity firm that focuses on the health care sector. Viracor-IBT’s workforce of nearly 270 employees will be retained, and the company will continue to use the Viracor-IBT name.

Related content